STRATEGY , ADVICE AND EDUCATION IN THE LIFE SCIENCES


       SSCBIO LTD

Expert Adviser in Cell Culture Technologies

ABOUT SSCBIO

SSC Bio is a limited liability company established to utilise key experience in advanced biological medicines, microbiology and biobanking in support of researchers, product developers, policy makers and other organisations. Its activity is based on the extensive knowledge and experience of its CEO Professor Glyn Stacey acquired over more than 30 years and extends to a network of connections with high level expertise.

 

Latest News

Glyn Stacey visiting collegaues at the Chinese Academy of Sciences this month in Beijing

WHAT WE OFFER

MINIBIOG

  • Professional employment:

  • Registered professional pathologist specialising  in microbiology.

  • Director SSC Bio Ltd.

  • Director International Stem Cell Banking Initiative.

  • Director for the UK Stem Cell Bank (2003-2017)

  • Senior scientist and divisional head at the National Institute for Biological Standards and Control in the UK (1998-2017)

  • Principal investigator and advisory board member for numerous UK, EU and international R&D projects in regenerative medicines, stem cell research and toxicology

  • Key competencies and knowledge areas: 

    • Cell substrates for the manufacture of biologicals.

    • Safety and quality issues for cells used in cell therapy, manufacture of biologicals and the development of cell-based assays and genetic reference materials.

    • Biobanking of diverse biomaterials e.g., animal cell lines, plant cultures, gametes.

    • Cryopreservation science and long term storage of biological materials.

    • International best practice guidance on cell and stem cell culture.

  • Key external positions held:

    • International Alliance for Biological Standardisation Gene and Cell Therapy Committee (2013-present)

    • Visiting Professor at the University of Bedfordhsire (2007-present) and University of Suffolk (2017-present)

    • UK Department of Health committee for the Safety of Blood Tissues and Organs (SaBTO) (2014-2015)

    • Coordinator for the NIBSC Stem Cell Open Forum (1999-2001),

TRACK RECORD IN SCIENCE, REGULATION AND TRAINING

  • Principal investigator for 24 significant UK, European and international R&D projects

  • Director and grant applicant for the UK Stem Cell Bank 2003-2017 (www.nibsc.org/ukstemcellbank).

  • Responsibility for cleanroom GMP facilities under HTA license (EUTCD) and scientific and technical work performed under ISO standards (ISO17025, ISO13485, ISO9000) 

  • Author for more than 100 per reviewed scientific papers and reviews, 45 book chapters and edited three science books

  • Secured more than £20M grants funded in the UK and the EU

  • Active involvement in the organisation and delivery of almost 50 national and international training courses and academic postgraduate teaching

Books edited:

‘Safety in Cell and Tissue Culture’, Eds. Stacey GN, Doyle, A. and Hambleton PH, Kluwer Acad. Publ., Dordrecht, 1998, ISBN 0-412-82790-5.


UKCCCR Guidelines for the Use of Cell Lines in Cancer Research (1999) UKCCCR special working party, First edition, UKCCCR, Lincoln’s Inn Fields, London.


Animal Cell Types, editor GN Stacey, In: Encyclopedia of Cell Technology. Wiley Interscience, editor in chief R Spier, Wiley Interscience, New York 2000.


Cell Culture Methods for in vitro Toxicology, Eds. Stacey, G.N., Doyle, A. and Ferro, M., Kluwer Acad. Publ., Dordrecht, 2001.


Medicines from Animal Cells, Eds Stacey GN and Davis JM, J Wiley & sons, Chichester, 27 April 2007, ISBN 9780470850947 .


Cryopreservation and Freezedrying Methods. Eds Day DG and Stacey GN, Humana Press, Totowa, USA, (2007).


Culture of Human Stem Cells. Eds Freshney IR, Stacey GN and Auerbach, J.M., (2007) John Wiley & Sons Inc., New Jersey. Published in Chinese may 2009.

Book chapters since 2007:

Stacey, G., Byrne, E. and Hawkins, J.R. (2007) DNA fingerprinting and the characterisation of Animal Cell Lines. In: Animal Cell Biotechnology, 2nd Edition. Ed Poertner, R, Humana press, Totowa, NJ, pp123-145.


Stacey GN. Quality Control of Human Stem Cell Lines.(2007) In: Human Embryonic Stem Cells (Human Cell Culture - Volume 6) Eds  J. Masters, B. Palsson, J. Thomson. Springer (Tokyo and new York), pp1-22.


Stacey G.N. Sourcing Human Embryonic Stem Cell Lines. In: Human Embryonic Stem Cells: A practical handbook Eds. Sullivan S, Cowan C. and Eggan K. John Wiley & Sons, in press (June 2007)


Stacey GN and Auerbach J.M. Quality Control of Stem Cell Lines. (2007) In: Culture of Stem Cells. Eds Freshney IR, Stacey GN and Auerbach, J.M., John Wiley & Sons,pp 1-22.


Stacey GN (2007) Risk assessment of cell culture procedures. (2007) Chapter 31. In: Medicines from Animal Cells, Eds Stacey GN and Davis JM, J Wiley & sons, Chichester, pp 569-588. ISBN 9780470850947


Stacey GN and Hunt CJ (2008) Banking Stem Cell Lines for Future Therapies.

Eds Polack J, Sakis Mantalaris and Sian Harding. Imperial College Press, pp229-251.

Stacey, GN. and Merten, O-W (2010) Host Cells and Cell Banking, In: Viral Vectors for Gene Therapy: Methods and Protocols. (Methods in Molecular Biology 1, 737). Eds Al-Rubeai M. and Merten O-W, Springer Science+Business Media LLC, pp45-88in press.

Elstner, A., Noack, A., Damaschun, A., Stacey, G., Arán, B., Gawronska, I., Veiga, A., Borstlap, J., & Kurtz, A. 2010. Ongoing dynamics in the regulatory landscape of human embryonic stem cell research. Cellular Therapy and Transplantation, 1, (4)

Clark, B.J., Baust, J.M., & Stacey, G. 2010. How much will the biobanking industry come to rely on private companies? Biopreservation and Biobanking, 8, (4) 179-180

Stacey, G.N. (2010) Cell Culture Contamination. In: Cancer Cell Culture: Methods and Protocols. Ed Cree, IA., Springer Science+Business media LLC, New York, pp77-91.


Stacey, G.N., Hawkins, JR. and Fleck, R.A. (2011) Cryopreservation and Banking of Cell Lines, in Animal Cell Culture: Essential Methods (ed J. M. Davis), John Wiley & Sons, Ltd, Chichester, UK. doi: 10.1002/9780470669815.ch6

Healy, L., Young, L. and Stacey, G. (2011) Stem Cell Banks: Preserving Cell Lines, Maintaining Genetic Integrity, and Advancing Research. In: Methods in Molecular Biology Human Pluripotent Stem Cells: Methods and Protocols. Eds R Wesselschmidt and P Schwartz. (Humana Press). Methods in Molecular Biology, 1, Volume 767, Human Pluripotent Stem Cells, Part 1, Pages 15-27.


DeSousa, P., Mcrae, S. and Stacey, G. (2012) Stem cells in the development of products for regenerative medicine. In : Regenerative Medicine: Stem Cells and the Liver. Ed. D Hay, CRC Press, pp77-98.


Stacey, G. (2012) Current Developments in Cell Culture Technology. In: New Technologies for Toxicity Testing. Edited by: Michael Balls, Robert Combes and Nirmala Bhogal, Landes-Bioscience/ Springer, pp1-11.


Stacey, G. (2012) Banking stem cells for research and clinical applications. In: S.B. Dunnett and Bjorkland, (Eds), Function Neural Transplantation III, Progress in Brain Research, V200, Elsevier.


Stacey, G. (2012) Sourcing and using stem cell lines for radiation research: Potential, challenges and good stem cell culture practice. Int J Radiat Biol. 88(10):703-8.

Mai, X.L., Luong, M.X.L., Smith, K.P., Crook, J.M. and Stacey, G.N. (2012) Biobanks for Pluripotent Stem Cells (Chapter 8). In: J.F. Loring and S.E. Petersen (eds), Human Stem Cell Manual (2nd Edn), Elsevier Inc., pp105-125.

Stacey G . (2014) The Challenge of Standardisation in Stem Cell Research and Development. Chapter2 In: Stem Cell Banking. Ed Ilic D, Springer, 2014, chapter 2, pp11-18.


Stacey GN, Coecke S, Price A, Healy L, Jennings P, Wilmes A, Pinset C, Sundstrom M. Myatt G. (2016) Ensuring the quality of stem cell derived models for toxicity testing. In: Validation of Alternative Methods for Toxicity Testing. Eds ESkes C and Whelan M. Springer. pp259-297.ISBN 978-3-319-33826-2


Stacey, G., Healy, H., Mann, J., Hunt, CJ., and Morris, J. (2016) Fundamental Points to Consider in the Cryopreservation and Shipment of Cells for Human Application. Chapter 6. In: Bioprocessing for Cell- based Therapies. Ed. Che Connon, Wiley-Blackwell. pp167-186.


Stacey GN. (2017) Stem Cell Banking: A Global Overview. In: Stem Cell Banking: Methods and Protocols. Eds J Crook and T Luwig. Human Press, Springer Science +Business Media LLC, USA.


Stacey GN and Hawkins JR (2017) Cell Lines: Applications and Biosafety, In: Biological Safety, Principles and Practices, 5th Edition, Eds DP Wooley and KB Byers. ASM Press, USA. pp299-326.  Chapter DOI: 10.1128/9781555819637.ch14


Crook JM, Stacey GN. Setting quality standards for stem cell banking, research and translation: The international stem cell banking initiative (Chapter 1). Ed D Ilic. Springer International Publishing AQ8 AG, 2014:3–9.

Scientific papers and reviews since 2007:

Adewumi O, Aflatoonian B, Ahrlund-Richter L, Amit M, Andrews PW, Beighton G, Bello PA, Benvenisty N, Berry LS, Bevan S, Blum B, Brooking J, Chen KG, Choo AB, Churchill GA, Corbel M, Damjanov I, Draper JS, Dvorak P, Emanuelsson K, Fleck RA, Ford A, Gertow K, Gertsenstein M, Gokhale PJ, Hamilton RS, Hampl A, Healy LE, Hovatta O, Hyllner J, Imreh MP, Itskovitz-Eldor J, Jackson J, Johnson JL, Jones M, Kee K, King BL, Knowles BB, Lako M, Lebrin F, Mallon BS, Manning D, Mayshar Y, McKay RD, Michalska AE, Mikkola M, Mileikovsky M, Minger SL, Moore HD, Mummery CL, Nagy A, Nakatsuji N, O'Brien CM, Oh SK, Olsson C, Otonkoski T, Park KY, Passier R, Patel H, Patel M, Pedersen R, Pera MF, Piekarczyk MS, Pera RA, Reubinoff BE, Robins AJ, Rossant J, Rugg-Gunn P, Schulz TC, Semb H, Sherrer ES, Siemen H, Stacey GN, Stojkovic M, Suemori H, Szatkiewicz J, Turetsky T, Tuuri T, van den Brink S, Vintersten K, Vuoristo S, Ward D, Weaver TA, Young LA, Zhang W. (2007) Characterization of human embryonic stem cell lines by the International Stem Cell Initiative. Nat Biotechnol. 25, 803-16. Epub 2007 Jun 17.


Masters, J.R. and Stacey G. (2007) Changing medium and passaging cell lines. Nature Protocols, 2; 2276-2284


Stacey, GN, and Day, JG, (2007) Long-term ex situ conservation of biological resources and the role of biological resource centres. Methods Mol. Biol., 368; 1-14.


Knezevic I, Stacey G, Petricciani J; WHO Study Group on cell substrates. Biologicals. 2008 May;36(3):203-11.

Day, J.G., Stacey, G.N. (2008) Biobanking (invited review). Mol Biotechnol. 40(2):202-13.

Borstlap J, Stacey G, Kurtz A, Elstner A, Damaschun A, Aran B, Veiga A, (2008) First evaluation of the European hESCreg, Nat Biotechnol. 26(8), 859-860


Borstlap J, Kurtz A, Stacey G, Elstner A, Damaschun A, Aran B, Gerlach JC, Izpisua JC, Veiga A, (2008) Development of a European Human Embryonic Stem Cell Registry - hESCreg, Regen Med.3(6), 945-951.


Stacey. G,.N. Challenges for Banking Human Stem Cell Lines. World Stem Cell Report, October 2008, Genetics Policy Institute, USA.


Stacey GN (2008) The challenging path from stem cells to therapy. Cryoletters, 29 (1); 73.


Stacey, GN, and Masters, JR (2008) Cryopreservation and banking of mammalian cell lines. Nature Protocols, 3; 1981-1989.


Elstner A, Damaschun A, Kurtz A, Stacey G, Aran B, Veiga A, Borstlap J, The changing landscape of European and international regulation on embryonic stem cell research, Stem Cell Research, in print February 2009 Mar;2(2):101-7. Epub 2008 Nov 17.PMID: 19383415


Andrews, P.W., Arias-Diaz, J., Auerbach, J., Alvarez, M., Ahrlund-Richter, L., Baker, D.,

Benvenisty, N., Ben-Josef, D., Blin, G., Borghese, L., Borstlap, J., Bruce, K., Brüstle, O., Buckle, R., Camby, C., Choo, A.B., Chen, W., Collins, D., Colman, A., Crombie, C., Crook, J.M., Cypess, R., De Sousa, P., Dhawan, J., Douay, L., Dvorak, P., Dyke, T., Eriksson, L., Firpo, M., Fitzgerald, C., Glover, C., Gokhale, P., Greene, M., Ha, H-Y., Hampl, A., Healy, L., Hei, D., Holm, F., Hovatta, O., Hunt, C., Hwang, S-M., Inamdar, M., Isasi, R., Itskovitz-Eldor, J., Jessie, N., Kim, D-W, Kirzner, R., Kiatpongsan, S., Knowles, B.B., Kuo, H-C., Laughlin, M., Lavon, N., Ludwig, T., Lakov, M., Lee, D-R., Macauley, J., McKay, R., Menasche, P., Menendez, P-M., Michalska, A., Mileikovskaia, M., Minger, S., Mishra, G., Moody, J., Montgomery, K., Morris, C., Mummery, C., Nagy, A., Nakamura, Y., Nakatsuji, N., Nishikawa, S-I, Oh, S., Oh, S-K, Olson, P., Otonkoski, T., M., Patole, M., Park, H-S., Pei, X., Pera, M., Rajala, K., Reubinoff, B., Robins, A., Rooke, H., Rumayor, V., Scotmann, H., Sherlock, J., Simon, C., Sipp, D., Skinner, R., Smith, D., Stacey, G.N., Stefanovic, S., Strehl, R., Taft, R, Takahashi, T., Talib, S., Terstegge, S., Turner, R., Tuuri, T., Yu, J., Zandstra, P., Zapata, A., Zeng, F., Zhou Q.,, Tannenbaum, S. (2009). Consensus guidance for banking and supply of human embryonic stem cell lines for research purposes. Stem Cell Reviews and Reports 5, pp301-314.


Peter W. Andrews, P.W. Benvenisty, N., Knowles, B.B., McKay, R.D.J., Oh, S.K.W., Pera, M.F., Rossant, J., Stacey, G.N. (2010) Human ES cell lines—introduction, In Vitro Cell.Dev.Biol.—Animal (2010) 46:167–168.


Crook, J.M., Hei, D. and Stacey, G.N. (2010) The International Stem Cell banking Initiative: Raising standards to bank on. In Vitro Cell.Dev.Biol.—Animal, 46; 169-172.


Akopian, V., Andrews, P.W., Beil, S., Benvenisty, N., Brehm, J., Christie, M., Ford, A., Fox, V., Gokhale, P.J., Healy, L., Holm, F., Hovatta, O., Knowles, B.B., Ludwig, T.E., McKay, R.D.G., Miyazaki, T., Nakatsuji, N., Oh, S.K.W., Pera, M.F., Rossant, J., Stacey, G.N., and Suemori, H. (2010) Comparison of defined culture systems for feeder cell free propagation of human embryonic stem cells. In Vitro Cellular & Developmental Biology – Animal. Volume 46, Numbers 3-4; 1071-2690.


Knezevic I, Stacey G, Petricciani J, Sheets R (on behalf of the WHO Study Group on Cell Substrates) (2010). Evaluation of cell substrates for the production of biologicals: Revision of WHO recommendations Report of the WHO Study Group on Cell Substrates for the Production of Biologicals, 22-23 April 2009, Bethesda, USA.  Biologicals; 38:162-169.


Young L., Sung, J., Stacey, G. and J Masters J.R. (2010) Detection of mycoplasma in cell cultures. Nature Protocols, 5; 929-934.


Hinxton Accord (2010) Statement on Policies and Practices Governing

Data and Materials Sharing and Intellectual Property in Stem Cell Science, Manchester, October 2010. http://www.hinxtongroup.org/consensus_HG10_FINAL.pdf


Vaught, J., Baust, J.G., Heacox, A.E., Riegman, P., Betsou, F., Mazur, P., Baust, J.M., Stacey, G., & Barnes, M. (2010). What are three actionable strategies to improve quality in biomedical research. Biopreservation and Biobanking, 8, (3) 121-125

Clark, B.J., Baust, J.M., & Stacey, G. (2010). How much will the biobanking industry come to rely on private companies? Biopreservation and Biobanking, 8, (4) 179-180

Luong MX, Auerbach J, Crook JM, Daheron L, Hei D, Lomax G, Loring JF, Ludwig T, Schlaeger TM, Smith KP, Stacey G, Xu RH, Zeng F.(2011)A call for standardized naming and reporting of human ESC and iPSC lines. Cell Stem Cell. 8(4):357-359.


Murdoch,A., Braude, P., Stacey, G., Courtney, A., Lawford Davies, J., Brison, D., Hunt, C., Moore, H., Sethe, for the Procurement Working Group of the National Clinical hESC Forum. (2011) The Procurement of cells for the derivation of human embryonic stem cell lines for therapeutic use: recommendations for good practice. Stem Cell Reviews and Reports, 8 (1), 91-99.


Amps K, Andrews PW, Anyfantis G, Armstrong L, Avery S, Baharvand H, Baker J, Baker D, Munoz MB, Beil S, Benvenisty N, Ben-Yosef D, Biancotti JC, Bosman A, Brena RM, Brison D, Caisander G, Camarasa MV, Chen J, Chiao E, Choi YM, Choo AB, Collins D, Colman A, Crook JM, Daley GQ, Dalton A, De Sousa PA, Denning C, Downie J, Dvorak P, Montgomery KD, Feki A, Ford A, Fox V, Fraga AM, Frumkin T, Ge L, Gokhale PJ, Golan-Lev T, Gourabi H, Gropp M, Guangxiu L, Hampl A, Harron K, Healy L, Herath W, Holm F, Hovatta O, Hyllner J, Inamdar MS, Irwanto AK, Ishii T, Jaconi M, Jin Y, Kimber S, Kiselev S, Knowles BB, Kopper O, Kukharenko V, Kuliev A, Lagarkova MA, Laird PW, Lako M, Laslett AL, Lavon N, Lee DR, Lee JE, Li C, Lim LS, Ludwig TE, Ma Y, Maltby E, Mateizel I, Mayshar Y, Mileikovsky M, Minger SL, Miyazaki T, Moon SY, Moore H, Mummery C, Nagy A, Nakatsuji N, Narwani K, Oh SK, Oh SK, Olson C, Otonkoski T, Pan F, Park IH, Pells S, Pera MF, Pereira LV, Qi O, Raj GS, Reubinoff B, Robins A, Robson P, Rossant J, Salekdeh GH, Schulz TC, Sermon K, Mohamed JS, Shen H, Sherrer E, Sidhu K, Sivarajah S, Skottman H, Spits C, Stacey GN, Strehl R, Strelchenko N, Suemori H, Sun B, Suuronen R, Takahashi K, Tuuri T, Venu P, Verlinsky Y, Oostwaard DW, Weisenberger DJ, Wu Y, Yamanaka S, Young L, Zhou Q. (2011) Screening ethnically diverse human embryonic stem cells identifies a chromosome 20 minimal amplicon conferring growth advantage. Nat Biotechnol. 29(12):1132-1144 PMID: 22119741.

Healy L, Young L, Stacey GN. (2011) Stem cell banks: preserving cell lines, maintaining genetic integrity, and advancing research. Methods Mol Biol.;767:15-27. PMID: 21822864

Stacey GN (2011) Cell culture contamination. Methods Mol Biol; 731:79-91.


Pistollato, F., Bremer-Hoffmann, S., Healy, L., Young, L. and Stacey, G. (2012) Standardisation of pluripotent stem cell cultures for toxicity testing, Expert Opinion On Drug Metabolism and Toxicology, 8(2):239-257.


Stacey G, Stephens N. (2012) Social science in a stem cell laboratory: what happened when social and life sciences met. Regen Med. 2012 Jan;7(1):117-126.


Isasi, R., Knoppers, B.M., Andrews, P.W. Bredenoord, A, Colman, A, Lee E-H, Hull, S Kim, O-J, Lomax, G, Morris, C, Sipp, D, Stacey, G, Wahlstrom, J, & Zeng F (2012) Disclosure and management of research findings in stem cell research and banking: policy statement. Regen Med ; 7 (3), 440-448.


Inamdar MS, Healy L, Sinha A, Stacey G.(2012) Global Solutions to the Challenges of Setting up and Managing a Stem Cell Laboratory. Stem Cell Rev., 8(3);:830-843.


Stacey G. (2012) Current developments in cell culture technology. Adv Exp Med Biol. 2012;745:1-13.


Stacey, G. (2012) Sourcing and Using Stem Cell Lines for Research: Potential, Challenges and Good Stem Cell Culture Practice. Int. J. Radiat. Biol. 88, 703-708.


Stacey G (2012) Banking stem cells for research and clinical applications. Prog Brain Res;200:41-58. doi: 10.1016/B978-0-444-59575-1.00003-X. PMID: 23195414


Sheridan, B., Stacey, G., Wilson, A., Ginty, P., Bravery, C. and Marshall D. (2012) Standards can help bring products to market. Bioprocess International, 10(4); 18-20.


Kohonen, P; Benfenati, E; Bower, D; Ceder, R; Crump, M; Cross, K; Grafström, R; Healey, L; Helma, C; Jeliazkova, N; Jeliazkov, V; Maggioni, S; Miller, S; Myatt, G; Rautenberg, M; Stacey, G; Willighagen, E; Wiseman, J; Hardy, B (2013) The ToxBank Data Warehouse: Supporting the Replacement of In Vivo Repeated Dose Systemic Toxicity Testing. Molecular Informatics. Special Issue: Advances in Computational Toxicology. 32; 47–63.

Stacey, G, Crook, JR, Hei, D, Ludwig, T, (2013) Banking iPSC lines: Lessons learnt from ES cells? Cell Stem Cell, 13: 385-388.

Viswanathan, S., Keating, A., Deans, R., Hematti, P., Prockop, D., Stroncek  D.F., Stacey, G., Weiss, D.J., Mason, C., Rao, M.S. (2014) Soliciting Strategies for Developing Cell-Based Reference Materials to Advance MSC Research and Clinical Translation. Stem Cells Dev.;23(11):1157-1167

Stacey, G.N. and Day, J.G. (2014) Putting cells to sleep for future science. Nature Biotechnology 32, 320–322; (2014) doi:10.1038/nbt.2869.

Isasi, R, Peter W. Andrews, PW, Baltz, JM, Bredenoord, AL, Burton, P, Chiu, I-M,  Hull, SC, Jung, J-W, Kurtz, A, Lomax, G, Ludwig, T, McDonald, M, Morris, C, Ng, HH, Rooke, H, Sharma, A, Stacey, GN, Williams, C, Zeng, F,and Knoppers BM. (2014) Identifiability and Privacy in Pluripotent Stem Cell Research. Cell Stem Cell, 14, 428-430.


Geraghty, RJ, Capes-Davis, A, Davis, JM, Downward, J, Freshney, RI, Knezevic, I, Lovell-Badge, R, Masters, JRW, Meredith, J, Stacey, GN, Thraves, P, and Vias M, (2014). Guidelines for the use of cell lines in biomedical research. British Journal of Cancer, 111(6):1021-46.  doi: 10.1038/bjc.2014.166.

Stacey, GN. Expert opinion section on cell culture contamination, Pharmaceutical Bioprocessing, Future Science Group 2014.


Kurtz, A, Stacey G, Kidane L, Seriola, A, Stachelscheid, H and Veiga A. Regulatory Insight into the European Human Pluripotent Stem Cell Registry. (2014) Stem Cells and Development. 23 Suppl 1:51-55. DOI: 10.1089/scd.2014.0319


Heslop JA, Hammond TG, Santeramo I, Tort Piella A, Hopp I, Zhou J, Baty R, Graziano EI, Proto Marco B, Caron A, Sköld P, Andrews PW, Baxter MA, Hay DC, Hamdam J, Sharpe ME, Patel S, Jones DR, Reinhardt J, Danen EH, Ben-David U, Stacey G, Björquist P,Piner J, Mills J, Rowe C, Pellegrini G, Sethu S, Antoine DJ, Cross MJ, Murray P, Williams DP, Kitteringham NR, Goldring CE, Park BK. Concise Review: Workshop Review: Understanding and Assessing the Risks of Stem Cell-Based Therapies. Stem Cells Transl Med. 2015 Feb 26. pii: sctm.2014-0110. [Epub ahead of print]


Andrews PW, Baker D, Benvinisty N, Miranda B, Bruce K, Brüstle O, Choi M, Choi YM, Crook JM, De Sousa PA, Dvorak P, Freund C, Firpo M, Furue MK, Gokhale P, Ha HY, Han E, Haupt S, Healy L, Hei DJ, Hovatta O, Hunt C, Hwang SM, Inamdar MS, Isasi RM, Jaconi M, Jekerle V, Kamthorn P, Kibbey MC, Knezevic I, Knowles BB, Koo SK, Laabi Y, Leopoldo L, Liu P, Lomax GP, Loring JF, Ludwig TE, Montgomery K, Mummery C, Nagy A, Nakamura Y, Nakatsuji N, Oh S, Oh SK, Otonkoski T, Pera M, Peschanski M, Pranke P, Rajala KM, Rao M, Ruttachuk R, Reubinoff B, Ricco L, Rooke H, Sipp D, Stacey GN, Suemori H, Takahashi TA, Takada K, Talib S, Tannenbaum S, Yuan BZ, Zeng F, Zhou Q.  (2015) Points to consider in the development of seed stocks of pluripotent stem cells for clinical applications. Regenerative Medicine. 10 (02s) doi: 10.2217/RME.14.93


French, A, Bravery, C, Smith, J, Chandra, A, Archibald, P, Gold, I, Artzi, N, Kim, H-W, Barker, RW, Meissner, A, Wu, JC, Knowles, J, Williams, D, Carden, G-C, Sipp, D, Oh, S, Loring, J, Rao, M, Reeve, B, Wall, I, Carr, AJ, Bure, K, Stacey, G, Karp, JR, Snyder, EY, Brindley, D, (2015) Enabling consistency in human pluripotent stem cell products for research and development for clinical applications through material standards. Stem Cells Translational Medicine, 4; 217-223.


Barry J, Hyllner J, Stacey G, Taylor CJ, Turner M. Setting up a Haplobank:  Issues and Solutions. Cell Stem Cell (2015) Curr Stem Cell Rep. DOI 10.1007/s40778-015-0011-7


Aoi T and Stacey G (2015) Impact of National and International Stem Cell Banking Initiatives on progress in the field of cell therapy: IABS-JST Joint Workshop: Summary for Session 5 Biologicals. 43, 399-401.


Hayakawa T,  Aoi T, Bravery C, Hoogendoorn K, Knezevic I, Koga J, Maeda D, Matsuyama A, McBlane J,  Morio T, Petricciani J, Rao M, Ridgway A, Sato S, Sato Y, Stacey G, Trouvin J-H, Umezawa A, Yamato M, Yano K, Yokote H, Yoshimatsu K, Zorzi-More P (2015). Report of the international conference on regulatory endeavors towards the sound development of human cell therapy products.  Biologicals. 43, 23-297.

Williams DJ, Archer R, Archibald P, Bantounas I, Baptista R, Barker R, Barry J, Bietrix F, Blair N, Braybrook J, Campbell J, Canham M, Chandra A, Foldes G, Gilmanshin R, Girard M, Gorjup E, Hewitt Z, Hourd P, Hyllner J, Jesson H, Kee J, Kerby J, Kotsopoulou J, Kowalski S, Leidel C, Marshall D, Masi L, McCall M, McCann C, Medcalf N, Moore H, Ozawa H, Pan D, Parmar M, Plant AL, Reinwald Y, Sebastian S, Stacey G, Thomas RJ, Thomas D, Thurman-Newell J, Turner M, Vitillo L, Wall I, Wilson A, Wolfrum J, Yang Y, Zimmerman H (2016) Comparability: manufacturing, characterization and controls, report of a UK Regenerative Medicine Platform Pluripotent Stem Cell Platform Workshop. Regen Med. 11, 5: 483-492.

Sakurai K, Kurtz A, Stacey G, Sheldon M, and Fujibuchi W (2016) First Proposal of Minimum Information About a Cellular Assay for Regenerative Medicine (MIACARM). Stem Cells Translational Medicine SCTM-15-0393. Epub July 2016.


Seltmann, S., Lekschas, F., Muller, R., Stachelscheid, H., Bittner, M-S., Zhang, W., Kidane, L., Seriola, A., Veiga, A., Stacey, GN., and Kurtz, A. (2016) hPSCreg––the human pluripotent stem cell registry. Nucleic Acids Research. Nucleic Acids Research, 44, Database issue D757–D763 doi: 10.1093/nar/gkv963

Pamies D, Bal-Price A, Simeonov A, Tagle D, Allen D, Gerhold D, Yin D, Pistollato F, Inutsuka T, Sullivan K, Stacey G, Salem H, Leist M, Daneshian M, Vemuri MC, McFarland F, Coecke S, Fitzpatrick  SC, Lakshmipathy U, Mack A, Wang WB, Daiju Y, Sekino Y,  Kanda Y, Smirnova L and Hartung T. (2016). t4 Workshop: Good Cell Culture Practice for stem cells and stem-cell-derived models. ALTEX Online first published August 23, 2016, version 2 http://dx.doi.org/10.14573/altex.1607121


Scarfe L, Brillant N, Kumar J, Ali N, Alrumayh A, Amali M, Barbellion S, Jones V, Niemeijer M, Potdevin S,  Roussignol G, Vaganov A, Barbaric I, Barrow M,  Burton N, Connell J, Dazzi F, Edsbagge J, French N, Holder J, Hutchinson C, Jones D, Kalber T, Lovatt C, Lythgoe M, Patel S, Patrick PS, Piner J, Reinhardt J, Ricci E, Sidaway J, Stacey GN, Starkey Lewis P, Sullivan G, Taylor A, Wilm B, Poptani H, Murray P, Park BK. npg Regenerative Medicine, npj Regenerative Medicine, 2 (1). ISSN 2057-3995.


Andrews PW, Ben-David U, Benvenisty N, Coffey P, Eggan K, Knowles BB, Nagy A, Pera M, Reubinoff B, Rugg-Gunn PJ, Stacey GN (2017) Assessing the safety of human pluripotent stem cells (PSCs) and their derivatives for clinical applications. Stem Cell Reports.11, 9(1); 1-4. 

Kim J-H, Kurtz A, Yuan B-Z, Zeng F, Lomax G, Loring JF, HYEON JU JI, Clarke L, Inambadr MS, Pera M. Firpo MT, Sheldon M,  Rahman N, O’Shea O, Pranke P,  Zhou Q, Isasi R, Rungsiwiwut R, Kawamata S, Oh S, Ludwig T, Masui T, Novak TJ, Takahashi T, Fujibutchi W, KOO,SK, Stacey GN, (2017) Report of the International Stem Cell Banking Initiative Workshop Activity: Current Hurdles and Progress in Seed-Stock Banking of Human Pluripotent Stem Cells. SCTM, 6; 1956-1962.

 

CONTACT ME

Have a particular challenge you’re trying to deal with? Contact me today and see what I can do for you.

High St, Barley, Royston SG8 8HZ, UK

+44 (0) 7950 425115

 
Screenshot 2018-01-22 at 16.32.19.png
Screenshot 2018-01-22 at 16.35.30.png
Screenshot 2018-01-22 at 16.52.07.png

Call me today and see how I can help.

 

Follow

Contact

+44 (0) 7950 425115

Address

High St, Barley, Royston SG8 8HZ, UK

©2018 BY SSCBIO LTD. PROUDLY CREATED WITH WIX.COM

This site was designed with the
.com
website builder. Create your website today.
Start Now